Diffusion Pharmaceuticals Earning Date (DFFN)

USA |NASDAQ |USD

DFFN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 15, 2022 Dec 2021 $-0.04 $-0.12 $-0.06
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 15, 2022 Dec 2021 $0.00 $0.00 $0.00

Diffusion Pharmaceuticals's next earnings date is Tuesday, Mar 15, 2022 for the fiscal quarter ending Dec 2021.

DFFN Earnings Date & History Chart

DFFN Earnings & Revenue Forecast

DFFN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 0 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.16 $-0.17 $-0.16

DFFN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.05 $-0.05 $-0.05
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.16 $-0.16 $-0.19

DFFN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

DFFN Earnings Date & Revenue History

DFFN Earnings History

|
Show More
Show More

DFFN Revenue History

|
Show More
Show More

Diffusion Pharmaceuticals Next Earnings Date & Report

DFFN Next Earnings Date & Report Preview: Dec 2021 (FQ)

DFFN's next earnings date is Tuesday, Mar 15, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 2 analysts, the average EPS estimation for Diffusion Pharmaceuticals's next quarterly earnings is $-0.04, with a low EPS estimation of $-0.04, and a high estimation of $-0.04.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.04, the last 2 month trend is $-0.04, and the 3 month trend is $-0.04.

Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Diffusion Pharmaceuticals Previous Earnings Dates & Reports

DFFN Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Diffusion Pharmaceuticals's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.

DFFN's earnings per share (EPS) was $-0.12, missing the consensus analysts forecast of $-0.04 by -200.00%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 200.00%, and lower than the same period a year before (Sep 2020) by 71.43%.

Revenues were $0.00.

The company reported a net income of $-12.20M.

Free cash flow for the quarter was $-2.97M , compared to $-3.33M last quarter and $-3.51M a year before.

DFFN ended the quarter with $67.89K in total debt, a decrease of -29.16% compared to the previous quarter, and a decrease of -61.13% compared to the same quarter a year before.

DFFN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Diffusion Pharmaceuticals's previous annual earnings date was Mar 17, 2021 for its fiscal year ended Dec 31, 2020.

DFFN's earnings per share (EPS) was $-0.30, missing the consensus analysts forecast of $-0.28 by 7.14% , and higher than the previous year's EPS (Dec 2019) by -86.05%.

Revenues were $0.00.

The company reported a net income of $-14.19M.

Diffusion Pharmaceuticals reported a free cash flow of $-13.55M for its fiscal year, compared to $-9.86M a year ago.

The company ended the fiscal year with $149.16K in total debt, a decrease of -39.62% compared to the previous year.